A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

RECRUITING

Memorial Sloan Kettering Cancer Center - New York, New York

COMPLETED

Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.

RECRUITING

The Sidney Kimmel Comprehensive Cancer Center, Baltimore

RECRUITING

Moffitt Cancer Center, Tampa

RECRUITING

The Kirklin Clinic of University of Alabama Birmingham Hospital, Birmingham

RECRUITING

Cleveland Clinic Lerner College of Medicine, Cleveland

RECRUITING

University of Michigan Rogel Cancer Center, Ann Arbor

RECRUITING

Barbara Ann Karmanos Cancer Institute, Detroit

COMPLETED

Froedtert and Medical College of Wisconsin, Milwaukee

RECRUITING

Washington University in St. Louis, St Louis

RECRUITING

University of Oklahoma Health Sciences Center, Oklahoma City

RECRUITING

Harold C. Simmons Comprehensive Cancer Center, Dallas

RECRUITING

University of Texas Health Science Center - San Antonio, San Antonio

RECRUITING

DHR Health Institute for Research & Development, Edinburg

RECRUITING

University of Colorado Hospital - Anschutz Medical Campus, Aurora

RECRUITING

Norris Comprehensive Cancer Center, Los Angeles

COMPLETED

University of California San Diego, La Jolla

RECRUITING

University of California Irvine Medical Center, Orange

RECRUITING

Virginia Mason Medical Center, Seattle

RECRUITING

Summit Cancer Centers - North Spokane, Spokane

RECRUITING

University of Texas MD Anderson Cancer Center, Houston